Works matching IS 15391604 AND DT 2014 AND VI 13 AND IP 1

Results: 9

Use of historical control data for assessing treatment effects in clinical trials.

Published in:

Pharmaceutical Statistics, 2014, v. 13, n. 1, p. 41, doi. 10.1002/pst.1589

By:

Viele, Kert;
Berry, Scott;
Neuenschwander, Beat;
Amzal, Billy;
Chen, Fang;
Enas, Nathan;
Hobbs, Brian;
Ibrahim, Joseph G.;
Kinnersley, Nelson;
Lindborg, Stacy;
Micallef, Sandrine;
Roychoudhury, Satrajit;
Thompson, Laura

Publication type:

Article

The current state of Bayesian methods in medical product development: survey results and recommendations from the DIA Bayesian Scientific Working Group.

Published in:

Pharmaceutical Statistics, 2014, v. 13, n. 1, p. 3, doi. 10.1002/pst.1595

By:

Natanegara, Fanni;
Neuenschwander, Beat;
Seaman, John W.;
Kinnersley, Nelson;
Heilmann, Cory R.;
Ohlssen, David;
Rochester, George

Publication type:

Article

Bayesian analysis for nonlinear mixed-effects models under heavy-tailed distributions.

Published in:

Pharmaceutical Statistics, 2014, v. 13, n. 1, p. 81, doi. 10.1002/pst.1598

By:

De la Cruz, Rolando

Publication type:

Article

A practical guide to Bayesian group sequential designs.

Published in:

Pharmaceutical Statistics, 2014, v. 13, n. 1, p. 71, doi. 10.1002/pst.1593

By:

Gsponer, Thomas;
Gerber, Florian;
Bornkamp, Björn;
Ohlssen, David;
Vandemeulebroecke, Marc;
Schmidli, Heinz

Publication type:

Article

Bayesian methods for design and analysis of safety trials.

Published in:

Pharmaceutical Statistics, 2014, v. 13, n. 1, p. 13, doi. 10.1002/pst.1586

By:

Price, Karen L.;
Amy Xia, H.;
Lakshminarayanan, Mani;
Madigan, David;
Manner, David;
Scott, John;
Stamey, James D.;
Thompson, Laura

Publication type:

Article

Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study.

Published in:

Pharmaceutical Statistics, 2014, v. 13, n. 1, p. 94, doi. 10.1002/pst.1604

By:

Stamey, James D.;
Beavers, Daniel P.;
Faries, Douglas;
Price, Karen L.;
Seaman, John W.

Publication type:

Article

Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis.

Published in:

Pharmaceutical Statistics, 2014, v. 13, n. 1, p. 55, doi. 10.1002/pst.1592

By:

Ohlssen, David;
Price, Karen L.;
Amy Xia, H.;
Hong, Hwanhee;
Kerman, Jouni;
Fu, Haoda;
Quartey, George;
Heilmann, Cory R.;
Ma, Haijun;
Carlin, Bradley P.

Publication type:

Article

Bayesian Methods in Medical Product Development and Regulatory Reviews.

Published in:

Pharmaceutical Statistics, 2014, v. 13, n. 1, p. 1, doi. 10.1002/pst.1608

By:

Price, Karen;
LaVange, Lisa

Publication type:

Article

Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products.

Published in:

Pharmaceutical Statistics, 2014, v. 13, n. 1, p. 25, doi. 10.1002/pst.1588

By:

Gamalo, Meg A.;
Tiwari, Ram C.;
LaVange, Lisa M.

Publication type:

Article